中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/28 | 3,948 | 3,948 | 3,848 | 3,903 | -3 | -0.1% | 3,104,400 |
| 2022/04/27 | 3,825 | 3,919 | 3,792 | 3,906 | +46 | +1.2% | 4,684,600 |
| 2022/04/26 | 3,995 | 4,027 | 3,811 | 3,860 | -262 | -6.4% | 4,120,600 |
| 2022/04/25 | 4,135 | 4,150 | 4,096 | 4,122 | -19 | -0.5% | 1,918,300 |
| 2022/04/22 | 4,188 | 4,196 | 4,108 | 4,141 | -57 | -1.4% | 1,459,200 |
| 2022/04/21 | 4,227 | 4,239 | 4,150 | 4,198 | -17 | -0.4% | 2,188,500 |
| 2022/04/20 | 4,182 | 4,252 | 4,161 | 4,215 | +38 | +0.9% | 1,872,900 |
| 2022/04/19 | 4,174 | 4,215 | 4,152 | 4,177 | -19 | -0.5% | 1,379,100 |
| 2022/04/18 | 4,242 | 4,246 | 4,148 | 4,196 | -68 | -1.6% | 1,034,100 |
| 2022/04/15 | 4,230 | 4,294 | 4,188 | 4,264 | -27 | -0.6% | 1,512,400 |
| 2022/04/14 | 4,297 | 4,320 | 4,267 | 4,291 | +35 | +0.8% | 1,921,400 |
| 2022/04/13 | 4,135 | 4,268 | 4,135 | 4,256 | +103 | +2.5% | 3,066,000 |
| 2022/04/12 | 4,175 | 4,227 | 4,136 | 4,153 | -35 | -0.8% | 1,825,600 |
| 2022/04/11 | 4,147 | 4,192 | 4,130 | 4,188 | +1 | ±0% | 1,793,700 |
| 2022/04/08 | 4,163 | 4,198 | 4,102 | 4,187 | +56 | +1.4% | 3,147,900 |
| 2022/04/07 | 4,100 | 4,139 | 4,078 | 4,131 | +60 | +1.5% | 2,514,200 |
| 2022/04/06 | 4,056 | 4,075 | 4,034 | 4,071 | -30 | -0.7% | 2,256,300 |
| 2022/04/05 | 4,144 | 4,164 | 4,072 | 4,101 | -9 | -0.2% | 2,242,700 |
| 2022/04/04 | 4,114 | 4,156 | 4,090 | 4,110 | +44 | +1.1% | 1,468,800 |
| 2022/04/01 | 4,077 | 4,096 | 4,023 | 4,066 | -31 | -0.8% | 2,603,000 |
| 2022/03/31 | 4,125 | 4,190 | 4,097 | 4,097 | -89 | -2.1% | 2,576,300 |
| 2022/03/30 | 4,215 | 4,255 | 4,143 | 4,186 | -14 | -0.3% | 1,905,500 |
| 2022/03/29 | 4,185 | 4,200 | 4,131 | 4,200 | +42 | +1% | 2,037,600 |
| 2022/03/28 | 4,151 | 4,174 | 4,127 | 4,158 | -15 | -0.4% | 1,237,800 |
| 2022/03/25 | 4,160 | 4,179 | 4,098 | 4,173 | +88 | +2.2% | 1,860,600 |
| 2022/03/24 | 4,088 | 4,103 | 4,036 | 4,085 | -50 | -1.2% | 1,931,000 |
| 2022/03/23 | 4,087 | 4,135 | 4,072 | 4,135 | +138 | +3.5% | 2,863,100 |
| 2022/03/22 | 3,996 | 3,999 | 3,953 | 3,997 | -28 | -0.7% | 2,080,300 |
| 2022/03/18 | 4,050 | 4,104 | 3,988 | 4,025 | +58 | +1.5% | 3,131,100 |
| 2022/03/17 | 3,950 | 3,989 | 3,854 | 3,967 | +108 | +2.8% | 2,482,000 |
| 2022/03/16 | 3,759 | 3,871 | 3,754 | 3,859 | +159 | +4.3% | 2,363,500 |
| 2022/03/15 | 3,643 | 3,712 | 3,637 | 3,700 | +49 | +1.3% | 1,573,500 |
| 2022/03/14 | 3,766 | 3,772 | 3,651 | 3,651 | -48 | -1.3% | 1,860,800 |
| 2022/03/11 | 3,756 | 3,769 | 3,671 | 3,699 | -57 | -1.5% | 2,549,500 |
| 2022/03/10 | 3,699 | 3,759 | 3,653 | 3,756 | +115 | +3.2% | 2,341,000 |
| 2022/03/09 | 3,676 | 3,677 | 3,617 | 3,641 | -40 | -1.1% | 1,562,500 |
| 2022/03/08 | 3,602 | 3,712 | 3,602 | 3,681 | +42 | +1.2% | 1,834,900 |
| 2022/03/07 | 3,629 | 3,660 | 3,605 | 3,639 | -48 | -1.3% | 1,645,400 |
| 2022/03/04 | 3,770 | 3,780 | 3,645 | 3,687 | -96 | -2.5% | 2,410,300 |
| 2022/03/03 | 3,800 | 3,807 | 3,765 | 3,783 | -7 | -0.2% | 1,566,200 |
| 2022/03/02 | 3,866 | 3,872 | 3,782 | 3,790 | -47 | -1.2% | 1,830,700 |
| 2022/03/01 | 3,806 | 3,894 | 3,806 | 3,837 | +37 | +1% | 2,196,900 |
| 2022/02/28 | 3,852 | 3,858 | 3,780 | 3,800 | -53 | -1.4% | 2,226,200 |
| 2022/02/25 | 3,885 | 3,913 | 3,844 | 3,853 | +2 | +0.1% | 2,135,700 |
| 2022/02/24 | 3,860 | 3,929 | 3,841 | 3,851 | -24 | -0.6% | 2,458,100 |
| 2022/02/22 | 3,875 | 3,982 | 3,830 | 3,875 | -34 | -0.9% | 2,046,100 |
| 2022/02/21 | 3,849 | 3,943 | 3,827 | 3,909 | +1 | ±0% | 1,392,200 |
| 2022/02/18 | 3,826 | 3,920 | 3,825 | 3,908 | +40 | +1% | 1,673,200 |
| 2022/02/17 | 3,980 | 3,992 | 3,866 | 3,868 | -147 | -3.7% | 1,843,600 |
| 2022/02/16 | 4,006 | 4,040 | 3,988 | 4,015 | +54 | +1.4% | 1,944,000 |
801～
850
件表示中 / 3756件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 735,800円 | +1.7% | +5.0% | 3.40% | 29.53倍 | 6.10倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 356,600円 | +6.0% | +4.0% | 2.19% | 22.00倍 | 4.07倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 421,400円 | -1.1% | +75.3% | 4.75% | 29.19倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 741,700円 | +2.2% | +28.0% | 1.89% | 11.87倍 | 1.44倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 158,000円 | +0.9% | +380.2% | 4.94% | 21.77倍 | 1.87倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
